Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer and infectious diseases, today announced an ag ...

BRL-201 is under clinical development by BRL Medicine and currently in Phase I for Diffuse Large B-Cell Lymphoma.

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satricabtagene autoleucel (satri-cel) has shown efficacy in gastric cancer, in a rare win for this type of cell therapy in a solid ...

GD2-CART01 is under clinical development by Bellicum Pharmaceuticals and currently in Phase I for Medulloblastoma.

INR:3574. best first move in chess New overseas drugs are urgently needed in clinical practice! Brosulumab's application for listing in China has entered ...

INR:5910. recently retired cricket players Bayer's vericiguat has applied for listing in China, and is expected to be approved simultaneously in ...

INR:4001. odi cricket highest score Innovent's PD-1 sales in the first quarter reached 400 million! The domestic strength competition has begun R&D Dail ...

INR:4675. how to play points rummy The survival rate of the "most toxic" breast cancer has increased! The "Fudan Program" for precision adjuvant treatmen ...

INR:5261. book of golden sands max win Yesterday, Innovent Biologics reached a cooperation agreement with Roche worth more than US$2 billion. Sales o ...

INR:4846. today lottry result The United States announced that it would provide free HIV prevention drugs to 200,000 people without health insurance coverage ...

INR:1624. my dress up darling season 2 Pfizer's SCD new drug rivipansel failed in Phase III clinical trial and its partner's stock price plummeted! J ...